Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Parkinson Disease Clinical Trials

72 recruiting trials for Parkinson Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
72
Total Trials
72
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT05635266

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical research to discover and...

Sponsor: Sanguine BiosciencesEnrolling: 200001 location
RECRUITINGNCT06528964

Proteinopathies Expression in Skin of Neurodegenerative Disorders

The goal of this observational study is to compare the aggregation pattern of proteinopathies (alpha-synuclein, amyloid-beta, phosphorylated tau and transactive response DNA...

Sponsor: Universidad Autonoma de San Luis PotosíEnrolling: 401 location
RECRUITINGNCT05919485

The Effects of Specific tDCS on Cognition in MCI

INTRODUCTION: Mild cognitive impairment (MCI) is a critical transitional stage in dementia related disorders. Dorsolateral prefrontal cortex (DLPFC), and the lateral parietal...

Sponsor: Istanbul Medipol University HospitalEnrolling: 1201 location
RECRUITINGNCT06295263

Application of AI Technology for the Diagnosis and Treatment of Geriatric Diseases

1\) Characteristics of handwriting, gait, speech, eye movements, biological samples (blood, urine, stool, saliva, etc.), images, EEG, and other relevant markers in patients with...

Sponsor: Qilu Hospital of Shandong UniversityEnrolling: 4601 location
RECRUITINGNCT03217396

Biomarkers of Synaptic Damage in Multiple Sclerosis

A prospective and retrospective cohort study of about five years will be performed on blood and cerebrospinal fluid samples taken for diagnostic reasons from recruited patients...

Sponsor: Neuromed IRCCSEnrolling: 3001 location
RECRUITINGNCT06906679

Upper Limb Rehabilitation in People With Parkinson's Disease:

This study evaluates the effectiveness of upper limb rehabilitation using an end-effector robotic device with exercises designed to improve movements, strength, and coordination...

Sponsor: IRCCS San Raffaele RomaEnrolling: 402 locations
RECRUITINGNCT07118956

Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease

The goal of this clinical trial is to learn whether 100HZ respiratory-gated vagus nerve stimulation (RAVANS) can improve the non-motor symptoms in people with Parkinson's disease...

Sponsor: Anhui Medical UniversityEnrolling: 601 location
RECRUITINGNCT06399731

Non-invasive Brain Stimulation for the Treatment of Mild Cognitive Impairment in Parkinson's Disease

This cross-over pilot study aims to study the acceptability of two methods of non-invasive brain stimulation for the treatment of Parkinson's disease mild cognitive impairment...

Sponsor: Amsterdam UMCEnrolling: 201 location
RECRUITINGNCT04715984

Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment

The goal of this study is to learn more about the brain activity underlying Parkinson's disease cognitive impairment. The investigators will utilize neural recordings from...

Sponsor: Vanderbilt University Medical CenterEnrolling: 751 location
RECRUITINGNCT06237868

rTMS Over the Dorsolateral Prefrontal Cortex for the Treatment of Impulse Control Disorders in Parkinson's Disease

This study's objective is to evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex (dlPFC) of patients with...

Sponsor: West Virginia UniversityEnrolling: 201 location
RECRUITINGNCT06548256

The Clinical Application of Clostridium Butyricum Miyairisan for Motor and Non-motor Symptoms in Parkinson's Disease

This is an open-label, single-center, non-randomized study to assess the efficacy of Clostridium Butyricum Miyairi on the motor and non-motor symptoms of Parkinson's disease

Sponsor: Kaohsiung Medical University Chung-Ho Memorial HospitalEnrolling: 4001 location
RECRUITINGNCT06151002

PD Frontline (Part of RAPSODI GD) Remote Assessment of People With Parkinson's

PD Frontline (part of RAPSODI GD) is an online study observational study with the goal of bringing People with Parkinson's to the frontline of research by getting them trial...

Sponsor: University College London HospitalsEnrolling: 48001 location
RECRUITINGNCT05986643

Brain Training to Improve Balance in Parkinson's Disease

People living with Parkinson's (PwP) rank balance problems amongst the most disabling symptom. Over time, balance function continues to decline and PwP go on to fall, affecting...

Sponsor: University of LeicesterEnrolling: 1001 location
RECRUITINGNCT06051877

Ocular Microtremor in Parkinson's Disease.

This is an exploratory, observational study that will use a novel handheld device - The iTremor ONE, which has been developed to rapidly, non-invasively assess and evaluate OMT...

Sponsor: Northumbria UniversityEnrolling: 402 locations
RECRUITINGNCT06791902

Study on Preliminary Safety and Efficacy of Adaptive DBS Aligned to Locomotor States to Improve Locomotor Functions in...

At present, there is no cure for Parkinson's disease. The standard treatment involves taking dopaminergic drugs. When drugs lose their effectiveness, they can be supplemented by...

Sponsor: Jocelyne BlochEnrolling: 101 location
RECRUITINGNCT04229056

COMPuter-assisted Self-training to Improve EXecutive Function

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest...

Sponsor: Bispebjerg HospitalEnrolling: 3072 locations
RECRUITINGPhase 2NCT06329141

A Study to Assess the Efficacy and Safety of Vutiglabridin in Early Parkinson's Disease Patients

1. Study Objective \- To assess the efficacy and safety of vutiglabridin in early Parkindson's disease patients 2. Background Glaceum Inc. has evaluated the safety,...

Sponsor: GlaceumEnrolling: 909 locations
RECRUITINGNCT07148700

Which Tools Better Predict Fall Risk in Parkinson's Disease: A Comparative Study of Objective, Self-Reported, and...

Introduction: Falls are common in Parkinson's disease (PD), affecting 30-90% of patients annually, with more than half experiencing recurrent falls. Identifying balance assessment...

Sponsor: Bezmialem Vakif UniversityEnrolling: 401 location
RECRUITINGNCT05680597

Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease

This project will determine the feasibility and efficacy of remote assessment and treatment of balance disorders in people with Parkinson's disease.

Sponsor: Oregon Health and Science UniversityEnrolling: 801 location
RECRUITINGNCT07187843

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

This observational study aims to systematically characterize a cohort of patients with early-stage Parkinson's disease (PD) attending the Movement Disorders Center of AUSL-IRCCS...

Sponsor: Azienda USL Reggio Emilia - IRCCSEnrolling: 1501 location
RECRUITINGPhase 2NCT04691661

Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease

This is a safety, tolerability, pharmacokinetic and efficacy study in subjects with Parkinson's disease

Sponsor: Il-Yang Pharm. Co., Ltd.Enrolling: 407 locations
RECRUITINGNCT04796506

Slow Wave Sleep As a Biomarker of Rehabilitation-induced Cognitive Improvement in PD

The purpose of this study is to investigate the effects of exercise rehabilitation on cognition and to evaluate slow wave sleep (SWS) as a biomarker and mediator of response to...

Sponsor: University of Colorado, DenverEnrolling: 1201 location
RECRUITINGNCT07204652

Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis

The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease. The main question...

Sponsor: CND Life SciencesEnrolling: 201 location
RECRUITINGNCT06363071

APA and PAS Training for Gait Initiation in Parkinson's Disease

Our research focused on understanding the interplay between brain excitability and balance function in patients with Parkinson's disease (PD), alongside evaluating effective...

Sponsor: Chang Gung UniversityEnrolling: 1001 location
RECRUITINGNCT06605183

10,000 Step Club: Community Walking Program for People with Parkinson's Disease

The 10,000 Step Club (10KSTC) is a 6-month community walking program for people with Parkinson's disease (PwP) and their caregivers in Las Vegas, Nevada (LV). This program will...

Sponsor: University of Nevada, Las VegasEnrolling: 601 location
RECRUITINGNCT05626608

Continuous Electrical Neuromodulation of the Globus Pallidus Intern in Parkinson's Disease by the Directional Electrode...

Many patients have benefited from the implantation of brain stimulation electrodes for the treatment of various motor signs of Parkinson's disease in the phase of motor...

Sponsor: University Hospital, MontpellierEnrolling: 101 location
RECRUITINGNCT03523104

Chinese PD-LRRK2 Registry

The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in...

Sponsor: Xiangya Hospital of Central South UniversityEnrolling: 10001 location
RECRUITINGNCT06804668

Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease

The goal of this clinical trial is to learn whether home-based transcranial direct current stimulation (tDCS) is safe and practical for people aged 40 to 70 years with Parkinson's...

Sponsor: Brigham and Women's HospitalEnrolling: 61 location
RECRUITINGNCT06306768

Remote Therapeutic Monitoring Exercise Tracking

The purpose of this study is to examine physical activity and exercise behaviors in people with Parkinson's Disease and Multiple Sclerosis over the course of 1-year using a...

Sponsor: Shirley Ryan AbilityLabEnrolling: 2001 location
RECRUITINGNCT05518617

Molecular and Functional Imaging in Monogenic PD.

In this study, the investigators aim to find a biomarker of Parkinson's disease. This is done using imaging scans called Positron Emission tomography (PET), Single Photon Emission...

Sponsor: University of ExeterEnrolling: 451 location
RECRUITINGNCT06965374

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced...

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some...

Sponsor: AbbVieEnrolling: 27019 locations
RECRUITINGNCT07217054

Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior...

The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease or REM Sleep...

Sponsor: CND Life SciencesEnrolling: 401 location
RECRUITINGNCT06482502

Validity of the 6-Minute Pegboard and Ring Test in Parkinson's Patients

Tests used to assess upper extremity endurance in Parkinson\'s patients are limited. This study aimed to investigate whether the 6-Minute Pegboard and Ring Test (6-MPRT),...

Sponsor: Emre ŞenocakEnrolling: 341 location
RECRUITINGNCT06291051

Evaluation of the Safety of Electrical Spinal Cord Stimulation in Parkinson's Patients Presenting With Painful...

Camptocormia is defined by abnormal flexion of the trunk, not fixed, present when standing and walking, resolves when lying down and often complicated by lower back pain. It can...

Sponsor: University Hospital, RouenEnrolling: 64 locations
RECRUITINGNCT05644327

Exercise to Improve Sleep in Parkinson's Disease

This study will investigate the impact of three common exercise modalities, cardiovascular, resistance, and multimodal (i.e., a combination of the previous two) training, on sleep...

Sponsor: McGill UniversityEnrolling: 1503 locations
RECRUITINGNCT06479083

Interdisciplinary + Intersectoral Telemedicine Evaluation, Coordination + Treatment in RhineMain+ Parkinson's Network

Project objective: To improve the health care of Parkinson's disease patients in the ParkinsonNetz RheinMain+. Hypothesis: Through the interdisciplinary and cross- sectoral...

Sponsor: Johannes Gutenberg University MainzEnrolling: 13542 locations
RECRUITINGPhase 1NCT06732180

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's Disease

The main goal of this clinical trial is to learn about the safety and tolerability of GT-02287. The questions it aims to answer are: * What medical problems do participants have...

Sponsor: Gain Therapeutics, Inc.Enrolling: 207 locations
RECRUITINGPhase 2NCT05766813

Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in patients with a diagnosis of Parkinson's Disease consistent with the UK...

Sponsor: Intra-Cellular Therapies, Inc.Enrolling: 13220 locations
RECRUITINGNCT07022522

Impact of Frequency-specific Subthalamic Nucleus Subregion Stimulation on Inhibitory Control in Parkinson's Disease

The core symptoms of Parkinson's disease (PD) include both motor and non-motor symptoms. Cognitive impairment is one of the most common non-motor symptoms in PD patients, with...

Sponsor: Beijing Tiantan HospitalEnrolling: 201 location
RECRUITINGNCT07299279

Movement Improves Brain Health and Cognition in Parkinson's Disease

Cognitive impairment is an acknowledged feature of Parkinson's disease (PD) and often coexists with the classic motor symptoms since their onset. Cognitive symptoms of PD can be...

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCSEnrolling: 1501 location
RECRUITINGNCT07434089

Impact of C-Mill Rehabilitation on the Gut-Brain Axis in Parkinson's Disease

The GM-REHAB-2025 study aims to evaluate the impact of physiotherapy interventions using the C-Mill treadmill, with and without semi-immersive virtual reality, on gut microbiota...

Sponsor: IRCCS Centro Neurolesi Bonino PulejoEnrolling: 601 location
RECRUITINGNCT05347407

Parkinson's Disease Biomarkers in Nerve Cells in the Gut

Parkinson's disease affects all the nerve cells in the body, including the ones in the gut. The gut contains its own nervous system, the enteric nervous system, and can be thought...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 601 location
RECRUITINGNCT06848192

The Parkinson's Disease Case-Control Study

The Parkinson's Disease Case-Control Study is a study of healthy volunteers and patients with Parkinson's disease aged 50-75 years living in Hangzhou, China. This study aims to...

Sponsor: Westlake UniversityEnrolling: 401 location
RECRUITINGNCT05881460

Vibrotactile Coordinated Reset: a Non-invasive Treatment for Parkinson's Disease 2

The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor function in people with Parkinson's disease (PD). vCR will be...

Sponsor: Synergic Medical Technologies, Inc.Enrolling: 301 location
RECRUITINGNCT06500182

The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years

There is no cure for Parkinson's disease, resulting in an interest for research in this domain. Non pharmacological measures remain essential, specifically physical activity....

Sponsor: Central Hospital Saint QuentinEnrolling: 361 location
RECRUITINGPhase 2NCT05266417

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.

Sponsor: Gateway Institute for Brain ResearchEnrolling: 562 locations
RECRUITINGNCT05218187

Robotic Gait Rehabilitation in Parkinson's Disease

The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to...

Sponsor: Indiana UniversityEnrolling: 301 location
RECRUITINGNCT03523052

Chinese PD-SNCA Registry

The purpose of the Chinese PD-SNCA Registry(CPD-SNCAR) is to develop a database of patients of Parkinson's disease with a-synuclein (SNCA) gene variants in mainland China.

Sponsor: Xiangya Hospital of Central South UniversityEnrolling: 30001 location
RECRUITINGNCT06909045

Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

The objective of the CLOSE-PD study is to compare the efficacy of adaptive deep brain stimulation (aDBS) with continue deep brain stimulation (cDBS) in patients with Parkinson's...

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 1304 locations
RECRUITINGNCT06707402

The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease

The goal of this clinical trial is to investigate if brisk walking can improve walking function in people with Parkinson's disease and what kind of brisk walking intervention that...

Sponsor: University of AarhusEnrolling: 1291 location

Showing 50 of 72 trials.Search all Parkinson Disease trials

Frequently Asked Questions

There are currently 72 clinical trials for Parkinson Disease, with 72 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Parkinson Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Parkinson Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.